Jamet Marie-Pierre, Gnemmi Viviane, Hachulla Éric, Dhaenens Claire-Marie, Bouchindhomme Brigitte, Delattre Claire, Glowacki François, Hatron Pierre-Yves, Lacour Arnaud, Lamblin Nicolas, Launay David, Leleu Xavier, Guiochon-Mantel Anne, Valleix Sophie, Maurage Claude-Alain, Copin Marie-Christine, Buob David
Departments of *Pathology †Internal Medicine ‡Biochemistry and Molecular Biology, UF Génopathies §Nephrology ∥Neurology ¶Cardiology #Hematology, CHRU de Lille, Regional Competence Center for Systemic Amyloidosis, and University Lille Nord de France, F-59000, Lille **Laboratoire de Génétique Moléculaire, Pharmacogénétique et Hormonologie, Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, CHU Paris Sud, Université Paris Sud, Le Kremlin Bicêtre ††Laboratoire de Biochimie et Génétique Moléculaire, Faculté de Médecine Paris, Université Paris Descartes, Sorbonne Paris Cité, Assistance Publique - Hôpitaux de Paris, Groupe Hospitalier Cochin-Hôtel Dieu; INSERM, Centre de Recherche des Cordeliers, URMS 872, équipe 17 ‡‡Pathology Department, Hôpital Tenon, Assistance Publique - Hôpitaux de Paris, Sorbonne Universités, UPMC Paris 6, Paris, France, F-75020.
Am J Surg Pathol. 2015 Aug;39(8):1035-44. doi: 10.1097/PAS.0000000000000430.
Accurate typing of amyloidosis is still a major issue for pathologists and clinicians. Besides clinical data and immunohistochemistry, the histologic distribution of amyloid could represent a useful tool to prevent typing errors, such as the misdiagnosis of hereditary and senile amyloidosis as light chain-related amyloidosis (AL). Minor salivary gland biopsy (MSGB) is a widely performed procedure for amyloidosis diagnosis and typing. In the largest clinicopathologic series of amyloid-containing MSGB specimens to date, we investigated for the first time whether amyloidosis subtypes can be distinguished according to their pattern of salivary amyloid deposition. The histologic distribution and semiquantification of amyloid within salivary tissue were thoroughly reassessed for each case using Congo red-fluorescence. Clinical data were retrospectively collected. The cohort included 92 patients with amyloid-containing minor salivary gland biopsies. The type of amyloidosis was AL in 51 patients (55.4%), non-V30M mutant ATTR in 10 (10.9%), V30M mutant ATTR in 8 (8.7%), serum amyloid A-derived amyloidosis (AA) in 6 (6.5%), wild-type ATTR in 4 (4.3%), gelsolin in 3 (3.3%), and unclassified in 10 (10.9%). Amyloid was more abundant in AL and AA compared with ATTR amyloidosis, because of more extensive basement membranes and vascular deposits. Conversely, non-V30M mutant ATTR and wt-ATTR were strongly associated with peculiar amyloid nodules located in close contact with salivary excretory ducts, with a specificity of 91.7%. In conclusion, our study suggests for the first time that MSGB, in addition to its high sensitivity for amyloidosis diagnosis, is a simple and effective tool for the recognition of ATTR amyloidosis.
准确诊断淀粉样变性病的类型仍然是病理学家和临床医生面临的主要问题。除了临床数据和免疫组织化学外,淀粉样蛋白的组织学分布可能是预防分型错误的有用工具,例如将遗传性和老年性淀粉样变性误诊为轻链相关淀粉样变性(AL)。小唾液腺活检(MSGB)是一种广泛用于淀粉样变性病诊断和分型的方法。在迄今为止最大的含淀粉样蛋白的MSGB标本临床病理系列研究中,我们首次研究了是否可以根据唾液淀粉样蛋白沉积模式区分淀粉样变性病亚型。使用刚果红荧光对每个病例唾液组织中淀粉样蛋白的组织学分布和半定量进行了全面重新评估。回顾性收集临床数据。该队列包括92例进行了含淀粉样蛋白的小唾液腺活检的患者。淀粉样变性病类型为AL的有51例(55.4%),非V30M突变型ATTR的有10例(10.9%),V30M突变型ATTR的有8例(8.7%),血清淀粉样蛋白A衍生的淀粉样变性病(AA)的有6例(6.5%),野生型ATTR的有4例(4.3%),凝溶胶蛋白的有3例(3.3%),未分类的有10例(10.9%)。与ATTR淀粉样变性病相比,AL和AA中的淀粉样蛋白含量更高,这是因为基底膜和血管沉积更广泛。相反,非V30M突变型ATTR和野生型ATTR与位于唾液排泄管附近的特殊淀粉样蛋白结节密切相关,特异性为91.7%。总之,我们的研究首次表明,MSGB除了对淀粉样变性病诊断具有高敏感性外,还是识别ATTR淀粉样变性病的简单有效工具。